Nuclear Medicine Market (By Type - Diagnostics, Therapeutics, Market By Modality - SPECT, PET, Alpha-Emitters, Beta-Emitters , Market By Application - Oncology, Cardiology, Neurology, Thyroid, Market By Procedures - Cardiovascular, Central Nervous System, Endocrine, Skeletal, Market By End-Users - Hospitals & Diagnostics Center, Research Institutes) - Global Industry Size, Share, Trends, and Forecast, 2018-2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 150

Introduction

Nuclear medicines or radiopharmaceuticals together are one of the most common drugs, used for the diagnosis of dysfunction in human body tissues. For both diagnostics and therapeutics reason nuclear medicines are used. Moreover, there are more than 30 specific radio pharmaceuticals used by medical practioners. Different forms of nuclear medicines are used in the treatment of cancer, neurological disorders, gastrointestinal, and other diseases.

Market Dynamics

The increasing prevalence of cancer and cardiac disorder are some of the major factors driving the growth of the market. Moreover, advent of alpha radioimmunotherapy (Rit)-based targeted cancer treatments, improvements in radiotracers, and investment through public and private partnerships to revolutionize diagnostic measures are some of the other factors propelling the growth of the market.

However, short life span of radiopharmaceuticals, high cost of these medicines, and shutting down of several nuclear reactors are some of the restraining factors hampering the growth of the market. Furthermore, upcoming radioisotopes and increasing usage across neurological applications are the opportunities for the growth of the market.

Market Classification and Overview

The global nuclear medicine market is segmented into type, modality, application, procedures, end-user, and region.

On the basis of type, the market is segmented into diagnostics and therapeutics.

Based on the modality, the market is segmented into SPECT, PET, alpha-emitters, beta-emitters, and others.

On the basis of application, the market is segmented into oncology, cardiology, neurology, thyroid, and others.

On the basis of procedures, the market is segmented into cardiovascular, central nervous system, endocrine, skeletal, and others.

On the basis of end-user, the market is segmented into hospitals & diagnostics center and research institutes.

Regional Overview

Geographically, the global nuclear medicine market is bifurcated into four regions such as North America, Europe, Asia Pacific (APAC), and Latin America, Middle East & Africa (LAMEA).

North America is expected to hold the major share during the forecast period 2018-2026 owing to the advancement of novel technologies for radioisotope productions, government funding, and company initiatives in the region.

Asia Pacific is expected to be the largest growing region during the forecasted period owing to the increasing demand for the nuclear medicines, increasing disposable income, and improving healthcare standards.

Europe is expected to dominate the market due to the well developed economic condition, advancement in healthcare infrastructure, and better government initiatives. Additionally, LAMEA is expected to hold the least share ue to lack of knowledge and poor healthcare facilities.

Report Coverage

Market

Nuclear Medicine  Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

Type, Modality, Application, Procedures, End-Users, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,

Player Profiling, Value Chain Analysis

Market Participants

The nuclear medicine market comprises of some of the major players such as

  • Mallinckrodt plc.
  • General Electric Co. (healthcare division),
  • Medtronic, Inc.
  • Bayer AG
  • Cardinal Health, Inc.
  • Lantheus Medical Imaging, Inc.
  • IBA Group

Market Segmentation

Market By Type

  • Diagnostic
  • Therapeutic

Market By Modality

  • SPECT
  • PET
  • Alpha-emitters
  • Beta-emitters
  • Others

Market By Application

  • Oncology
  • Cardiology
  • Neurology
  • Thyroid
  • Others

 

Market By Procedures

  • Cardiovascular
  • Central Nervous System
  • Endocrine
  • Skeletal
  • Others

 

Market By End-Users

  • Hospitals and diagnostic centers
  • Research institutes
  • Others

 

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA


Related Reports

Wound Dressing Market (By Product - Traditional, Advanced [Moist, Foam, Alginate, Film, Hydrocolloid, Hydrogel], Antimicrobial [Silver, Non - Silver], Interactive [ Biomaterials, Skin - Substitute]) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction Moisture wound dressing is a clinical technique to create a moist around the wound in order to speed up the healing process and reduce scabs and scarring for beautiful skin. Moisture wound dressing promotes the growth and migration of new cells and also maintains the proteins that are essential for wound closure. The report provides analysis of global moisture wound

Infection Surveillance Solutions Market (By Product and Services - Software [ On-premise, Web-based], Services; By Infection Type - Surgical Site Infections (SSI), Blood Stream Infections (BSI), Urinary Tract Infections (UTI), Others; By End-use - Long Term Care Facilities, Hospitals, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction    Healthcare associated Infections (HAIs), or nosocomial contaminations, are the measure of the patient prosperity and health concerns coming about because of poor cleanliness, diminished patient immunity, carelessness and extra medicinal services uses. Infection surveillance is designed to constantly monito

Hematology Diagnostics Market (By Product - Instrument [Analyzers, Flow Cytometers, Others], Consumables, Reagents, Stains, Others; By Test Type - Blood Count, Platelet function, Hemoglobin, Hematocrit; By End Use - Hospitals, Diagnostic Labs, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction Hematology is a part of drug, which manages the study of blood, blood illnesses and blood-forming organs. Hematology incorporates issues related with white platelets, red platelets, bone marrow, lymph, and platelets. It additionally influences the fluid part of blood known as plasma. Hematology incorporates different IVD advancements, such as blood analysis, stream

Healthcare Contract Research Organization (CRO) Market (By Product - Drug Discovery, Pre-Clinical, Clinical; By Service - Project Management/Clinical Supply Management, Data Management, Regulatory/Medical Affairs, Medical Writing, Clinical Monitoring, Quality Management/ Assurance, Bio-statistics, Investigator Payments, Laboratory, Patient and site Recruitment, Technology, Others) Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction    Healthcare contract research organization (CRO) provides support and services as biologic assay development, clinical research, commercialization, preclinical research, clinical trials management and biopharmaceutical development to biotechnology, pharmaceutical and medical device industries. Healthcare co

Antibiotic Resistance Market (By Disease - cUTI, cIAI, BSI, CDI, ABSSSI, HABP/VABP, CABP; By Pathogen - Acinetobacter Baumannii, Pseudomonas Aeruginosa, Staphylococcus Aureus, E. coli/K. Pneumoniae, Streptococcus Pneumoniae, Clostridium difficile, Enterococcus faecium, Haemophilus Influenzae; By Drug Class - Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination therapies, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction    Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans and animals body, and the infections they cause

Sterility Indicators Market (By Type - Chemical Indicators, Biological Indicators; By Technique - Heat Sterilization, Low Temperature Sterilization, Filtration, Sterilization, Radiation Sterilization, Liquid Sterilization; By End-user - Hospitals, Pharmaceutical Companies, Medical device Companies, Clinical, laboratories/Research Centers, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction The global sterility indicators market was valued at USD 547.5 million in 2017 in terms of revenue. It is expected to grow at a CAGR of 10.8% during the forecast period. Stringent regulations regarding healthcare products and greater emphasis on sterility parameters and methods for the prevention of Hospital Acquired Infections are anticipated to dr

Cart Summary